0001209191-20-001230.txt : 20200103
0001209191-20-001230.hdr.sgml : 20200103
20200103172122
ACCESSION NUMBER: 0001209191-20-001230
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MacLean Michael F
CENTRAL INDEX KEY: 0001383731
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 20506821
MAIL ADDRESS:
STREET 1: 14 CAMBRIDGE CENTER
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-207-0202
MAIL ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-02
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001383731
MacLean Michael F
C/O AKCEA THERAPEUTICS, INC.
22 BOSTON WHARF ROAD, 9TH FLOOR
BOSTON
MA
02210
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
16.99
2020-01-02
4
A
0
57000
0.00
A
2030-01-01
Common Stock
57000
57000
D
The shares vest as follows: 1/4th of the shares vest one year after January 2, 2020; 1/48th of the shares vest monthly thereafter over the next three years.
/s/ Joshua F. Patterson, Attorney-in-Fact
2020-01-03